Celsion Corporation (CLSN)

[john1045]

Celsion Co. (NASDAQ:CLSN) CEO Michael H. Tardugno bought 7,500 shares of the business’s stock in a transaction on Monday, October 29th. The stock was bought at an average price of $2.06 per share, for a total transaction of $15,450.00. Following the purchase, the chief executive officer now directly owns 27,700 shares of the company’s stock, valued at $57,062. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

A hedge fund recently raised its stake in Celsion stock. BlackRock Inc. lifted its holdings in shares of Celsion Co. (NASDAQ:CLSN) by 72.3% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 114,844 shares of the biotechnology company’s stock after acquiring an additional 48,194 shares during the period. BlackRock Inc. owned approximately 0.65% of Celsion worth $339,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 4.76% of the company’s stock.

https://www.fairfieldcurrent.com/2018/11/02/celsion-co-clsn-ceo-acquires-15450-00-in-stock.html